| Full Name | Rush M Twilley |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | Cmr 427, Apo, Armed Forces Europe |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760528426 | NPI | - | NPPES |
| 285071101 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | BP10023063 (Texas) | Secondary |
| 207P00000X | Emergency Medicine | N9489 (Texas) | Primary |
| Entity Name | Clark Fork Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538384987 PECOS PAC ID: 1850491960 Enrollment ID: O20070702000592 |
News Archive
The University of Illinois Chicago has received a $2.5 million grant to better prepare primary care physicians to treat substance use disorders and mental health conditions in rural and urban underserved populations.
MIS416, a novel microparticle-based immune response modifier, demonstrated the ability to significantly reduce the number and size of metastatic tumors in preclinical mouse models of lung and breast cancers, Innate Therapeutics (formerly Virionyx Corporation) announced.
This commitment follows the donation by the UK government to Viet Nam of 415,050 doses of the University of Oxford-AstraZeneca vaccine in August 2021.
New data from the JUPITER study demonstrated that Crestor (rosuvastatin calcium) 20 mg significantly reduced major cardiovascular (CV) events (defined in this study as the combined risk of myocardial infarction, stroke, arterial revascularization, hospitalization for unstable angina, or death from CV causes) by a dramatic 44% compared to placebo (p<0.001) among men and women with elevated hsCRP but low to normal cholesterol levels.
› Verified 9 days ago
| Entity Name | Signify Health Medical Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750845863 PECOS PAC ID: 2163764424 Enrollment ID: O20190828001034 |
News Archive
The University of Illinois Chicago has received a $2.5 million grant to better prepare primary care physicians to treat substance use disorders and mental health conditions in rural and urban underserved populations.
MIS416, a novel microparticle-based immune response modifier, demonstrated the ability to significantly reduce the number and size of metastatic tumors in preclinical mouse models of lung and breast cancers, Innate Therapeutics (formerly Virionyx Corporation) announced.
This commitment follows the donation by the UK government to Viet Nam of 415,050 doses of the University of Oxford-AstraZeneca vaccine in August 2021.
New data from the JUPITER study demonstrated that Crestor (rosuvastatin calcium) 20 mg significantly reduced major cardiovascular (CV) events (defined in this study as the combined risk of myocardial infarction, stroke, arterial revascularization, hospitalization for unstable angina, or death from CV causes) by a dramatic 44% compared to placebo (p<0.001) among men and women with elevated hsCRP but low to normal cholesterol levels.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rush M Twilley, MD Cmr 427, Box 4226, Apo, AE 09630 Ph: () - | Rush M Twilley, MD Cmr 427, Box 4226, Apo, AE 09630 Ph: (328) 556-9239 |
News Archive
The University of Illinois Chicago has received a $2.5 million grant to better prepare primary care physicians to treat substance use disorders and mental health conditions in rural and urban underserved populations.
MIS416, a novel microparticle-based immune response modifier, demonstrated the ability to significantly reduce the number and size of metastatic tumors in preclinical mouse models of lung and breast cancers, Innate Therapeutics (formerly Virionyx Corporation) announced.
This commitment follows the donation by the UK government to Viet Nam of 415,050 doses of the University of Oxford-AstraZeneca vaccine in August 2021.
New data from the JUPITER study demonstrated that Crestor (rosuvastatin calcium) 20 mg significantly reduced major cardiovascular (CV) events (defined in this study as the combined risk of myocardial infarction, stroke, arterial revascularization, hospitalization for unstable angina, or death from CV causes) by a dramatic 44% compared to placebo (p<0.001) among men and women with elevated hsCRP but low to normal cholesterol levels.
› Verified 9 days ago
Dr. Geoffrey C Alexander, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Phone: 314-590-6322 | |
Dr. Ana Paola Geluso, MD, MBA Emergency Medicine Medicare: Medicare Enrolled Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Phone: 314-590-6322 | |
Dr. Peter Jon Benson, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: Hq Soceur, Unit 30400, Apo, AE 09131 Phone: 011-497-116807620 | |
Dr. Jeffrey Alan Lawson, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: Landstuhl Regional Medical Center, Cmr 402, Apo, AE 09180 Phone: 845-667-1371 | |
Victor Alberto Pacheco-fowler, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Phone: 314-590-6322 | |
Dr. Mindy Sueyeon Park, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: Unit 33100 Box Landstuhl, Apo, AE 09180 Phone: 314-590-4913 | |
Robert E Thaxton, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: Unit 33100, Apo, AE 09180 Phone: 314-590-8072 |